1 Rush Institute for Healthy Aging, Centers for Disease Control and Prevention, Atlanta, GA, USA 2 Department of Internal Medicine, Centers for Disease Control and Prevention, Atlanta, GA, USA 3 ...

Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

Objectives To report efficacy of adjuvant cenobamate in adults with Lennox-Gastaut syndrome (LGS) following cannabidiol. Methodology A retrospective record review was conducted of patients with LGS ...

1 Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong 2 Department of Clinical and Experimental Epilepsy, ...

1 Alzheimer Centre and VU University Medical Centre, Amsterdam, The Netherlands 2 Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands 3 Department of Neurology and MRI ...

Correspondence to Dr Claudio Liguori, Department of Systems Medicine, Neurophysiopathology Unit, University of Rome “Tor Vergata”, Viale Oxford 81 Rome 00133, Italy; dott.claudioliguori{at}yahoo.it ...

Dr Paul T Francis, Dementia Research Laboratory, Division of Biomolecular Sciences, Guy’s, King’s and St Thomas’ Schools of Biomedical Sciences, King’s College, St Thomas Street, London SE1 9RT, UK.

Objectives OCARINA II (NCT05232825) is a Phase III, randomised, open-label, controlled study of a novel subcutaneous formulation of ocrelizumab, designed to demonstrate non-inferior serum exposure of ...

Service of Neurology Hospital Clinic and Institut d’Invesigación Biomèdica August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain Cuban Multiple Sclerosis Society and Multiple ...

Correspondence to Dr W-Ludo van der Pol, Department of Neurology and Neurosurgery F02.230, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht 3508 GA, The ...